Literature DB >> 15625072

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.

Paul Muntner1, Jiang He, Brad C Astor, Aaron R Folsom, Josef Coresh.   

Abstract

Some risk factors for coronary heart disease (CHD) incidence in the general population are not associated with CHD incidence among patients with ESRD but have not been well characterized in chronic kidney disease (CKD). The association of several risk factors with CHD incidence was studied among participants with CKD in the population-based Atherosclerosis Risk in Communities (ARIC) Study. CHD risk factors and estimated GFR using serum creatinine were measured among 807 ARIC participants with CKD (estimated GFR between 15 and 59 ml/min per 1.73 m(2)). The incidence of CHD during 10.5 yr of follow-up was 6.3, 8.5, and 14.4 per 1000 person-years among ARIC participants with an estimated GFR of >/=90, 60 to 89, and 15 to 59 ml/min per 1.73 m(2), respectively. After adjustment for age, race, gender, and ARIC field center, among those with CKD, the relative risk (95% confidence interval) of CHD was 1.65 (1.01 to 2.67) for current smoking, 2.02 (1.27 to 3.22) for hypertension, 3.06 (2.01 to 4.67) for diabetes, and 1.96 (1.14 to 3.36) for anemia. The comparably adjusted relative risks of CHD for each standard deviation higher total and HDL cholesterol were 1.50 (1.25 to 1.71) and 0.79 (0.62 to 1.01), respectively, and 1.38 (1.13 to 1.69), 1.24 (1.06 to 1.46), 0.65 (0.54 to 0.79), and 1.38 (1.19 to 1.59) for waist circumference, leukocyte count, serum albumin, and fibrinogen, respectively. CHD risk factors in the general population remain predictive among patients with CKD. Given the high risk for CHD among patients with CKD, control of these risk factors may have a substantial impact on their excess burden of CHD.

Entities:  

Mesh:

Year:  2004        PMID: 15625072     DOI: 10.1681/ASN.2004080656

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  153 in total

1.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 2.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

3.  Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

Authors:  Nosratola D Vaziri; Kaveh Navab; Pavan Gollapudi; Hamid Moradi; Madeleine V Pahl; Cyril H Barton; Alan M Fogelman; Mohamad Navab
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

4.  Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population.

Authors:  Daisuke Uchida; Hiroo Kawarazaki; Yugo Shibagaki; Takashi Yasuda; Naoto Tominaga; Tsuyoshi Watanabe; Koichi Asahi; Kunitoshi Iseki; Chiho Iseki; Kazuhiko Tsuruya; Kunihiro Yamagata; Toshiki Moriyama; Ichiei Narita; Shoichi Fujimoto; Tsuneo Konta; Masahide Kondo; Masato Kasahara; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2014-08-24       Impact factor: 2.801

Review 5.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

6.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

7.  Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis.

Authors:  Jui-Ting Hsiung; Carola-Ellen Kleine; Neda Naderi; Christina Park; Melissa Soohoo; Hamid Moradi; Connie M Rhee; Yoshitsugu Obi; Joel D Kopple; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  J Ren Nutr       Date:  2019-01-11       Impact factor: 3.655

8.  Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes.

Authors:  Meda E Pavkov; Peter H Bennett; Maurice L Sievers; Jonathan Krakoff; Desmond E Williams; William C Knowler; Robert G Nelson
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Metabolic abnormalities are present in adults with elevated serum cystatin C.

Authors:  Paul Muntner; Suma Vupputuri; Josef Coresh; Jaime Uribarri; Caroline S Fox
Journal:  Kidney Int       Date:  2009-03-18       Impact factor: 10.612

10.  Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.

Authors:  Yun Li; Lihua Zhang; Yong Gu; Chuanming Hao; Tongying Zhu
Journal:  Perit Dial Int       Date:  2013-03-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.